- Home
- BBGI vs BOLT Comparison
BBGI vs BOLT Comparison
Compare BBGI & BOLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BBGI
- BOLT
- Stock Information
- Founded
- BBGI 1961
- BOLT 2015
- Country
- BBGI United States
- BOLT United States
- Employees
- BBGI N/A
- BOLT N/A
- Industry
- BBGI Broadcasting
- BOLT Biotechnology: Pharmaceutical Preparations
- Sector
- BBGI Consumer Discretionary
- BOLT Health Care
- Exchange
- BBGI Nasdaq
- BOLT Nasdaq
- Market Cap
- BBGI 8.3M
- BOLT 9.4M
- IPO Year
- BBGI 2000
- BOLT 2021
- Fundamental
- Price
- BBGI $5.55
- BOLT $5.37
- Analyst Decision
- BBGI
- BOLT Buy
- Analyst Count
- BBGI 0
- BOLT 3
- Target Price
- BBGI N/A
- BOLT $47.50
- AVG Volume (30 Days)
- BBGI 2.9K
- BOLT 8.9K
- Earning Date
- BBGI 11-04-2025
- BOLT 11-11-2025
- Dividend Yield
- BBGI N/A
- BOLT N/A
- EPS Growth
- BBGI N/A
- BOLT N/A
- EPS
- BBGI N/A
- BOLT N/A
- Revenue
- BBGI $227,387,784.00
- BOLT $4,167,000.00
- Revenue This Year
- BBGI $5.02
- BOLT N/A
- Revenue Next Year
- BBGI N/A
- BOLT N/A
- P/E Ratio
- BBGI N/A
- BOLT N/A
- Revenue Growth
- BBGI N/A
- BOLT N/A
- 52 Week Low
- BBGI $3.67
- BOLT $4.59
- 52 Week High
- BBGI $14.95
- BOLT $14.36
- Technical
- Relative Strength Index (RSI)
- BBGI 73.07
- BOLT 52.49
- Support Level
- BBGI $5.27
- BOLT $5.04
- Resistance Level
- BBGI $4.80
- BOLT $5.50
- Average True Range (ATR)
- BBGI 0.11
- BOLT 0.23
- MACD
- BBGI 0.08
- BOLT 0.05
- Stochastic Oscillator
- BBGI 99.95
- BOLT 81.27
About BBGI Beasley Broadcast Group Inc.
Beasley Broadcast Group Inc is a multi-platform media company, whose primary business is operating radio stations throughout the United States. The company offers local and national advertisers integrated marketing solutions across audio, digital and event platforms. It owns and operates stations in the following markets: Atlanta, GA, Augusta, GA, Boston, MA, Charlotte, NC, Detroit, MI, Fayetteville, NC, Fort Myers-Naples, FL, Las Vegas, NV, Middlesex, NJ, Monmouth, NJ, Morristown, NJ, Philadelphia, PA, Tampa-Saint Petersburg, FL, and Wilmington, DE. The company operates in two segments Audio and Digital.
About BOLT Bolt Biotherapeutics Inc.
Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. The company's pipeline candidates are built on deep expertise in myeloid biology and cancer drug development. The company's proprietary Boltbody ISAC platform technology combines tumor-targeting antibodies with immune-stimulating linker-payloads. The company's pipeline consists of BDC-1001, BDC-3042, and Next-Gen ISAC.